Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02746263 · ClinicalTrials.gov registry record · Phase 4
Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain
A Phase 4 study, sponsored by Mallinckrodt.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT02746263 is a Phase 4 study that was terminated before completion, run by Mallinckrodt. The registered enrollment target is 1 participants.
The verdict
NCT02746263, a Phase 4 study, was terminated before completion, sponsored by Mallinckrodt.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to compare intravenous (IV) and oral acetaminophen for the treatment of acute moderate to severe pain in combination with standard patient-controlled analgesia (PCA) in adult subjects following total knee replacement.
Interventions
- DRUG Morphine
- DRUG IV acetaminophen
- DRUG Oral acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-04-27 |
| Est. Completion | 2016-05-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02746263
The ClinicalTrials.gov registry entry for NCT02746263 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Morphine is the first listed.
NCT02746263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02746263 about?
NCT02746263 is a clinical study titled "Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain". The purpose of this study is to compare intravenous (IV) and oral acetaminophen for the treatment of acute moderate to severe pain in combination with standard patient-controlled analgesia (PCA) in adult subjects following total knee replacement.
What is the current status of trial NCT02746263?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2016-04-27. Estimated completion is 2016-05-05.
What interventions are being tested in trial NCT02746263?
The interventions under investigation include: Morphine (DRUG), IV acetaminophen (DRUG), Oral acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02746263?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.